Back Stocks profile

Stock analysis tool for investors

Medico Remedies Ltd.

NSE: MEDICO | BSE:540937

₹39.50 -0.52 (-1.30%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

39.20

Today’s High

40.90

52W low

34.80

52W High

93.00

Open Price

40.80

Prev. Close

36.8500

Volume

76107.00

Value

3006226.50

Fundamentals

Market Cap

327.80

Price to Earnings

39.50

Price to Book Value

6.30

Dividend Yield

0.00

PE to Growth

2.70

Op Revenue TTM

144.92

Net Profit TTM

8.29

Cash From Operating Activity

2.44

Return on Equity %

15.83

EMA & SMA

Bullish Moving Averages

1

Bearish Moving Averages

15

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

100

Week

100

Month

100

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

39.87

PIVOT

First Resistance

40.53

Second Resistance

41.57

Third Resistance

42.23

First Support

38.83

Second Support

38.17

Third Support

37.13

Relative Strength Index

46.1

Money Flow Index

50.85

MACD

-0.07

MACD Signal

-0.11

Average True Range

1.8

Average Directional Index

23

Rate of Change (21)

10.8

Rate of Change (125)

-53.67

Commodity Channel Index

-28.4

Williams %R

-81.3

BETA

1 Month

-0.04

3 Month

0.37

1 Year

0.32

3 Year

PRICE CHANGE ANALYSIS

-3.14%

1 Week

Low

High

38.9

41.75

7.19%

1 Month

Low

High

36.45

43.8

-16.93%

3 Months

Low

High

34.8

49.1

-54.23%

6 Months

Low

High

34.8

92

-44.79%

1 Year

Low

High

34.8

92.95

Bigul
28 Jun 2024

Medico Remedies Ltd - 540937 - Closure of Trading Window

The Trading Window is closed for all Insiders, Designated Persons and their immediate relatives from 1st July, 2024 up to the expiry of 48 hours post the date of declaration of Unaudited Financial Results for the quarter ended 30th June, 2024.
Bigul
28 May 2024

Medico Remedies Ltd - 540937 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached Annual Secretarial Compliance Report for the year ended 31st March, 2024.
Bigul
11 May 2024

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached Newspaper publication for quarter and year ended 31st March, 2024.
Bigul
09 May 2024

Medico Remedies Ltd - 540937 - Financial Results For March, 2024

Please find attached Audited Standalone Financial Results for quarter and year ended 31st March, 2024.
Bigul
09 May 2024

Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today ie. 9th May, 2024 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31 March, 2024 and Audited Financial Statements for the year ended on 31st March, 2024 along with the Auditor's Report thereon. 2. Board's Report and its annexures, Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March, 2024.
Bigul
30 Apr 2024

Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting

Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 ,inter alia, to consider and approve We hereby inform you that the meeting of the Board of Directors of the Company will be held on Thursday, 9th May, 2024, inter alia, to transact the following business: 1. To consider and approve, Audited Financial Results for the quarter ended 31st March, 2024 and Audited Financial Statements for the year ended on 31st March, 2024
Bigul
17 Apr 2024

Medico Remedies Ltd - 540937 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024

We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2024.
Bigul
15 Apr 2024

Medico Remedies Ltd - 540937 - Compliance Certificate For The Year Ended On 31St March, 2024 Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015

We hereby submit the duly signed Compliance Certificate for the year ended on 31st March, 2024 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015
Bigul
27 Mar 2024

Medico Remedies Ltd - 540937 - Closure of Trading Window

The Trading Window for dealing in the equity shares of the Company is closed for all Insiders, Designated Persons and their immediate relatives from 1st April, 2024 upto the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended 31st March, 2024.
Bigul
22 Mar 2024

Medico Remedies Ltd - 540937 - Clarification sought from Medico Remedies Ltd

The Exchange has sought clarification from Medico Remedies Ltd on March 22, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
See all News

FAQs

The latest market price of Medico Remedies Ltd. on NSE was Rs. 39.50 as of today.

The opening share price of Medico Remedies Ltd. was Rs. 40.80 as of today.

The 52-week high share price of Medico Remedies Ltd. was Rs. 93.00.

The 52 week low share price of Medico Remedies Ltd. was Rs. 34.80.

Please find Corporate actions section for more details.

The PE ratio of Medico Remedies Ltd. is 2.70. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

The latest bonus issue declared by Medico Remedies Ltd. was as of 2021-11-16. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Medico Remedies Ltd. was as of 2023-03-16. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Medico Remedies Ltd..

Close

Let's Open Free Demat Account